Brevibloc Injection
Product Images NDC 10019-670

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Brevibloc (NDC 10019-670). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Structural Formula)

Chemical structure of esmolol hydrochloride shown as a molecular formula with a benzene ring and associated chemical groups, including ester, ether, and amine functional groups.*

FDA Label Image

Figure 1: Two-port Intravia Bag (Image 01)

An instructional diagram of an intravenous injection bag showing a medication port for withdrawing initial bolus and a delivery port for administration. The bag is likely related to the BREVIBLOC (esmolol hydrochloride) injection product by Baxter Healthcare Company.*

FDA Label Image

Representative Brevibloc 10mg Premier Pro Container Label 10019-670-10 (Image 03)

Label for BREVIBLOC PREMIXED Injection, esmolol hydrochloride 10 mg/mL in sodium chloride, packaged as 2,500 mg/250 mL intravenous solution. Manufactured by Baxter Healthcare Company, this sterile, nonpyrogenic, iso-osmotic injection is supplied in a 250 mL container for single intravenous use, with no preservative added.*

FDA Label Image

Representative Carton Label 10019-670-10 (Image 04)

This image shows text panels for BREVIBLOC Premixed Injection containing esmolol hydrochloride in sodium chloride at 10 mg/mL concentration, packaged as 10 x 250 mL single-use Intravia containers. The label includes storage instructions, trademark information, coding for product inquiry, expiration, and lot number placeholders. It is labeled for intravenous use and manufactured by Baxter Healthcare Company.*

FDA Label Image

Representative Brevibloc 20mg Premier Pro Container Label 10019-666-10 (Image 05)

Brevibloc Premixed Double Strength Injection label showing esmolol hydrochloride in sodium chloride at 20 mg/mL strength. The vial contains 100 mL with a total of 2,000 mg. Label indicates the drug is for single intravenous use only, sterile, nonpyrogenic, and made by Baxter Healthcare Company, USA. Storage and usage cautions are included.*

FDA Label Image

Representative Container Label Ndc 10019-666-10 (Image 06)

Brevibloc Premixed Double Strength Injection 20 mg/mL intravenous injection label showing product name, strength, dosage form, and manufacturer Baxter Healthcare Company. Includes storage instructions at 25°C with excursions permitted to 15-30°C, barcode placement areas, NDC 10019-666-10, and batch/expiration placeholders on a white background.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.